Status:
UNKNOWN
Acceptance and Commitment Therapy for Parents of Children With Cancer
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Childhood Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current study aims to develop a theoretically driven ACT intervention and examine its effects among parents of children with cancer. The objectives are: 1. To examine the effects of ACT intervent...
Detailed Description
A pilot study will be used to evaluate the feasibility and acceptability of ACT intervention protocol in Chinese parents of children with cancer. A two-arm parallel randomized controlled trial (RCT) w...
Eligibility Criteria
Inclusion
- The parents will be recruited if parent-child dyads fulfill the following eligibility criteria
- Parents:
- Over the ages of 18 years old
- Fathers or mothers who are the primary caregivers (provide the largest amount of daily care) of Children with cancer
- Living together with the childhood cancer patients
- Can communicate in Chinese and follow the instructions of the study
- Can be accessible by telephone or by email
- Children:
- Between the ages of 2 to 17 years old
- Newly diagnosed of cancer by a physician in the previous six months and currently receive treatment
Exclusion
- Parents or their child who were currently participating in another cancer-related intervention study
- Parents or their children who are cognitive impaired
- Children in critical condition or palliative care
Key Trial Info
Start Date :
June 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04870697
Start Date
June 28 2021
End Date
January 1 2022
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Soochow University
Suzhou, China